SASMAR PHARMACEUTICALS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SASMAR PHARMACEUTICALS
Largest movements
- Receivables within one year -€179,723
down €179,723 (-48.3%), from €372,464 to €192,741
of which Trade receivables: -€102,178
- Receivables after one year +€140,997
up €140,997 (+5.4%), from €2.6m to €2.8m
- Deferred charges and accrued income -€77,066
down €77,066 (-87.8%), from €87,810 to €10,744
- Profit (loss) carried forward +€133,640
up €133,640 (+58.7%), from €227,540 to €361,179
- Accrued charges and deferred income -€81,085
no longer reported in 2025 (was €81,085)
- Trade debts -€72,019
down €72,019 (-3.4%), from €2.1m to €2.0m
- Tax, wage and social debts -€57,401
down €57,401 (-76.8%), from €74,748 to €17,347
of which Remuneration and social security: -€52,243
- Debts after one year -€43,818
down €43,818 (-6.4%), from €681,333 to €637,515
- Turnover -€188,673
down €188,673 (-9.6%), from €2.0m to €1.8m
- Staff costs -€183,496
down €183,496 (-53.6%), from €342,037 to €158,541
- Purchases and services -€121,285
down €121,285 (-7.6%), from €1.6m to €1.5m
- Depreciation -€114,533
down €114,533 (-94.3%), from €121,438 to €6,905
- Gross operating margin -€67,388
down €67,388 (-18.4%), from €366,473 to €299,086
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,195,764 | €3,073,916 | -€121,849 | -3.8% |
| Fixed assets | 21/28 | €93,435 | €95,409 | +€1,973 | +2.1% |
| Intangible fixed assets | 21 | €2,500 | €4,869 | +€2,369 | +94.8% |
| Tangible fixed assets | 22/27 | €89,690 | €89,294 | -€396 | -0.4% |
| Plant, machinery and equipment | 23 | €87,924 | €87,925 | +€1 | 0.0% |
| Furniture and vehicles | 24 | €1,766 | €1,369 | -€397 | -22.5% |
| Financial fixed assets | 28 | €1,246 | €1,246 | -€0 | 0.0% |
| Current assets | 29/58 | €3,102,329 | €2,978,507 | -€123,822 | -4.0% |
| Amounts receivable after more than one year | 29 | €2,631,108 | €2,772,105 | +€140,997 | +5.4% |
| Trade receivables | 290 | €2,631,108 | €2,772,105 | +€140,997 | +5.4% |
| Amounts receivable within one year | 40/41 | €372,464 | €192,741 | -€179,723 | -48.3% |
| Trade receivables | 40 | €137,554 | €35,376 | -€102,178 | -74.3% |
| Other amounts receivable | 41 | €234,910 | €157,365 | -€77,545 | -33.0% |
| Cash at bank and in hand | 54/58 | €10,947 | €2,917 | -€8,030 | -73.3% |
| Deferred charges and accrued income | 490/1 | €87,810 | €10,744 | -€77,066 | -87.8% |
| Total equity and liabilities | 10/49 | €3,195,764 | €3,073,916 | -€121,849 | -3.8% |
| Equity | 10/15 | €246,140 | €379,779 | +€133,640 | +54.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | €227,540 | €361,179 | +€133,640 | +58.7% |
| Amounts payable | 17/49 | €2,949,624 | €2,694,136 | -€255,488 | -8.7% |
| Amounts payable after more than one year | 17 | €681,333 | €637,515 | -€43,818 | -6.4% |
| Other amounts payable | 178/9 | €681,333 | €637,515 | -€43,818 | -6.4% |
| Amounts payable within one year | 42/48 | €2,187,206 | €2,056,621 | -€130,585 | -6.0% |
| Financial debts | 43 | €3,399 | €2,235 | -€1,164 | -34.3% |
| Credit institutions | 430/8 | €3,399 | - | -€3,399 | |
| Other loans | 439 | - | €2,235 | +€2,235 | |
| Trade debts | 44 | €2,109,059 | €2,037,040 | -€72,019 | -3.4% |
| Suppliers | 440/4 | €2,109,059 | €2,037,040 | -€72,019 | -3.4% |
| Taxes, remuneration and social security | 45 | €74,748 | €17,347 | -€57,401 | -76.8% |
| Taxes | 450/3 | €5,158 | - | -€5,158 | |
| Remuneration and social security | 454/9 | €69,590 | €17,347 | -€52,243 | -75.1% |
| Accrued charges and deferred income | 492/3 | €81,085 | - | -€81,085 | |
| Turnover | 70 | €1,965,734 | €1,777,061 | -€188,673 | -9.6% |
| Goods, raw materials, services and sundry goods | 60/61 | €1,599,261 | €1,477,975 | -€121,285 | -7.6% |
| Remuneration, social security and pensions | 62 | €342,037 | €158,541 | -€183,496 | -53.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €121,438 | €6,905 | -€114,533 | -94.3% |
| Gross operating margin | 9900 | €366,473 | €299,086 | -€67,388 | -18.4% |
| Operating profit (loss) | 9901 | -€97,001 | €133,640 | +€230,641 | |
| Profit (loss) for the period before taxes | 9903 | -€97,001 | €133,640 | +€230,641 | |
| Profit (loss) for the period | 9904 | -€97,001 | €133,640 | +€230,641 | |
| Profit (loss) for the period to be appropriated | 9905 | -€97,001 | €133,640 | +€230,641 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.